TreeWAS
Search
Variant clusters
Hospitalization Episode Statistics (HES)
Genetic variants: 36,212
Diagnostic terms: × 19,155
Association results: = 693,640,860
Self-Reported Statistics (SRS)
Genetic variants: 28,458
Diagnostic terms: × 474
Association results: = 13,489,092
About
Frequently Asked Questions
Citation
Download association data
for this variant in csv format
Share this page

Variant-specific associations

rs9943876
log Bayes Factor = 6.56692
Chromosome 13   position 32,927,894  (GRCh37) Explore rs9943876 on Ensembl!
Variant rs9943876 is part of Cluster X0016

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)
Hierarchical visualisation How to interpret this figure?
Associations at terminal nodes are shown if p(effect) ≥
Click here to show this figure without filtering.
Click on a node to zoom (except terminal nodes).
Download this figure in format
Results table
Term Risk
posterior probability
 No effect
posterior probability
 Protective
posterior probability
  
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs
1.000 0.000 0.000
T36-T50 Poisoning by drugs, medicaments and biological substances
1.000 0.000 0.000
T42.4 Benzodiazepines
0.999 0.001 0.000
T42.6 Other antiepileptic and sedative-hypnotic drugs
0.996 0.004 0.000
T43 Poisoning by psychotropic drugs, not elsewhere classified
0.996 0.004 0.000
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]
0.995 0.005 0.000
T43.0 Tricyclic and tetracyclic antidepressants
0.966 0.034 0.000
T40.4 Other synthetic narcotics
0.934 0.066 0.000
T46 Poisoning by agents primarily affecting the cardiovascular system
0.932 0.068 0.000
T40.2 Other opioids
0.931 0.069 0.000
T43.2 Other and unspecified antidepressants
0.903 0.097 0.000
T40.6 Other and unspecified narcotics
0.898 0.102 0.000
T43.3 Phenothiazine antipsychotics and neuroleptics
0.892 0.108 0.000
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified
0.861 0.139 0.000
T36 Poisoning by systemic antibiotics
0.856 0.144 0.000
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified
0.826 0.174 0.000
T46.5 Other antihypertensive drugs, not elsewhere classified
0.812 0.188 0.000
T43.4 Butyrophenone and thioxanthene neuroleptics
0.807 0.193 0.000
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants
0.800 0.200 0.000
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified
0.797 0.203 0.000
T43.9 Psychotropic drug, unspecified
0.787 0.212 0.000
T46.1 Calcium-channel blockers
0.783 0.217 0.000
T46.4 Angiotensin-converting-enzyme inhibitors
0.782 0.218 0.000
T40.5 Cocaine
0.771 0.229 0.000
C44.3 Skin of other and unspecified parts of face
0.000 0.235 0.765
T37 Poisoning by other systemic anti-infectives and antiparasitics
0.761 0.239 0.000
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system
0.760 0.240 0.000
T36.0 Penicillins
0.758 0.242 0.000
C44 Other malignant neoplasms of skin
0.000 0.242 0.758
T42.1 Iminostilbenes
0.754 0.246 0.000
T47 Poisoning by agents primarily affecting gastro-intestinal system
0.749 0.251 0.000
T42.3 Barbiturates
0.748 0.252 0.000
T44 Poisoning by drugs primarily affecting the autonomic nervous system
0.747 0.253 0.000
T40.1 Heroin
0.743 0.257 0.000
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances
0.730 0.270 0.000
C44.0 Skin of lip
0.000 0.272 0.728
C44.2 Skin of ear and external auricular canal
0.000 0.277 0.723
T42.5 Mixed antiepileptics, not elsewhere classified
0.717 0.283 0.000
T42.2 Succinimides and oxazolidinediones
0.717 0.283 0.000
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs
0.717 0.283 0.000
T41 Poisoning by anaesthetics and therapeutic gases
0.717 0.283 0.000
T43.8 Other psychotropic drugs, not elsewhere classified
0.714 0.286 0.000
T43.1 Monoamine-oxidase-inhibitor antidepressants
0.714 0.286 0.000
T40.9 Other and unspecified psychodysleptics [hallucinogens]
0.713 0.286 0.000
T40.8 Lysergide [LSD]
0.713 0.286 0.000
T40.7 Cannabis (derivatives)
0.713 0.286 0.000
T40.3 Methadone
0.713 0.286 0.000
T40.0 Opium
0.713 0.286 0.000
T45.0 Antiallergic and antiemetic drugs
0.699 0.301 0.000
C44.5 Skin of trunk
0.000 0.305 0.695
T42.0 Hydantoin derivatives
0.693 0.307 0.000
T43.6 Psychostimulants with abuse potential
0.683 0.317 0.000
C44.7 Skin of lower limb, including hip
0.000 0.319 0.681
T46.9 Other and unspecified agents primarily affecting the cardiovascular system
0.668 0.332 0.000
T46.8 Antivaricose drugs, including sclerosing agents
0.668 0.332 0.000
T46.7 Peripheral vasodilators
0.668 0.332 0.000
T46.3 Coronary vasodilators, not elsewhere classified
0.668 0.332 0.000
T46.2 Other antidysrhythmic drugs, not elsewhere classified
0.668 0.332 0.000
T46.0 Cardiac-stimulant glycosides and drugs of similar action
0.668 0.332 0.000
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified
0.654 0.346 0.000
T38.8 Other and unspecified hormones and their synthetic substitutes
0.646 0.354 0.000
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs
0.637 0.363 0.000
C44.6 Skin of upper limb, including shoulder
0.000 0.367 0.633
T38.1 Thyroid hormones and substitutes
0.627 0.373 0.000
T36.9 Systemic antibiotic, unspecified
0.613 0.386 0.000
T36.8 Other systemic antibiotics
0.613 0.386 0.000
T36.7 Antifungal antibiotics, systemically used
0.613 0.386 0.000
T36.6 Rifamycins
0.613 0.386 0.000
T36.5 Aminoglycosides
0.613 0.386 0.000
T36.4 Tetracyclines
0.613 0.386 0.000
T36.2 Chloramphenicol group
0.613 0.386 0.000
T36.1 Cefalosporins and other Beta-lactam antibiotics
0.613 0.386 0.000
T36.3 Macrolides
0.598 0.402 0.000
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs
0.593 0.407 0.000
T38.9 Other and unspecified hormone antagonists
0.592 0.408 0.000
T38.7 Androgens and anabolic congeners
0.592 0.408 0.000
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified
0.592 0.408 0.000
T38.5 Other oestrogens and progestogens
0.592 0.408 0.000
T38.4 Oral contraceptives
0.592 0.408 0.000
T38.2 Antithyroid drugs
0.592 0.408 0.000
T38.0 Glucocorticoids and synthetic analogues
0.592 0.408 0.000
T37.8 Other specified systemic anti-infectives and antiparasitics
0.590 0.410 0.000
T43.5 Other and unspecified antipsychotics and neuroleptics
0.590 0.410 0.000
T48.5 Anti-common-cold drugs
0.588 0.412 0.000
T47.2 Stimulant laxatives
0.587 0.413 0.000
T45.2 Vitamins, not elsewhere classified
0.581 0.418 0.000
T45.1 Antineoplastic and immunosuppressive drugs
0.571 0.429 0.000
T45.9 Primarily systemic and haematological agent, unspecified
0.571 0.429 0.000
T45.8 Other primarily systemic and haematological agents
0.571 0.429 0.000
T45.7 Anticoagulant antagonists, vitamin K and other coagulants
0.571 0.429 0.000
T45.6 Fibrinolysis-affecting drugs
0.571 0.429 0.000
T45.4 Iron and its compounds
0.571 0.429 0.000
T45.3 Enzymes, not elsewhere classified
0.571 0.429 0.000
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics
0.560 0.440 0.000
T47.4 Other laxatives
0.546 0.453 0.000
T37.9 Systemic anti-infective and antiparasitic, unspecified
0.546 0.454 0.000
T37.5 Antiviral drugs
0.546 0.454 0.000
T37.4 Anthelminthics
0.546 0.454 0.000
T37.3 Other antiprotozoal drugs
0.546 0.454 0.000
T37.2 Antimalarials and drugs acting on other blood protozoa
0.546 0.454 0.000
T37.1 Antimycobacterial drugs
0.546 0.454 0.000
T37.0 Sulphonamides
0.546 0.454 0.000
T48.7 Other and unspecified agents primarily acting on the respiratory system
0.545 0.455 0.000
T48.6 Antiasthmatics, not elsewhere classified
0.545 0.455 0.000
T48.4 Expectorants
0.545 0.455 0.000
T48.3 Antitussives
0.545 0.455 0.000
T48.2 Other and unspecified agents primarily acting on muscles
0.545 0.455 0.000
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]
0.545 0.455 0.000
T48.0 Oxytocic drugs
0.545 0.455 0.000
C44.8 Overlapping lesion of skin
0.000 0.457 0.543
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified
0.537 0.463 0.000
T47.8 Other agents primarily affecting the gastro-intestinal system
0.537 0.463 0.000
T47.7 Emetics
0.537 0.463 0.000
T47.6 Antidiarrhoeal drugs
0.537 0.463 0.000
T47.5 Digestants
0.537 0.463 0.000
T47.3 Saline and osmotic laxatives
0.537 0.463 0.000
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified
0.536 0.464 0.000
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified
0.536 0.464 0.000
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified
0.536 0.464 0.000
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified
0.536 0.464 0.000
T44.2 Ganglionic blocking drugs, not elsewhere classified
0.536 0.464 0.000
T44.1 Other parasympathomimetics [cholinergics]
0.536 0.464 0.000
T44.0 Anticholinesterase agents
0.536 0.464 0.000
T50.4 Drugs affecting uric acid metabolism
0.534 0.466 0.000
T47.0 Histamine H(2)-receptor antagonists
0.531 0.468 0.000
T50.7 Analeptics and opioid receptor antagonists
0.524 0.476 0.000
T50.6 Antidotes and chelating agents, not elsewhere classified
0.524 0.476 0.000
T50.5 Appetite depressants
0.524 0.476 0.000
T50.3 Electrolytic, caloric and water-balance agents
0.524 0.476 0.000
T50.1 Loop [high-ceiling] diuretics
0.524 0.476 0.000
T50.0 Mineralocorticoids and their antagonists
0.524 0.476 0.000
T50.9 Other and unspecified drugs, medicaments and biological substances
0.519 0.481 0.000
T41.5 Therapeutic gases
0.514 0.486 0.000
T41.4 Anaesthetic, unspecified
0.514 0.486 0.000
T41.3 Local anaesthetics
0.514 0.486 0.000
T41.2 Other and unspecified general anaesthetics
0.514 0.486 0.000
T41.1 Intravenous anaesthetics
0.514 0.486 0.000
T41.0 Inhaled anaesthetics
0.514 0.486 0.000
T49.9 Topical agent, unspecified
0.514 0.486 0.000
T49.8 Other topical agents
0.514 0.486 0.000
T49.7 Dental drugs, topically applied
0.514 0.486 0.000
T49.6 Otorhinolaryngological drugs and preparations
0.514 0.486 0.000
T49.5 Ophthalmological drugs and preparations
0.514 0.486 0.000
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations
0.514 0.486 0.000
T49.3 Emollients, demulcents and protectants
0.514 0.486 0.000
T49.2 Local astringents and local detergents
0.514 0.486 0.000
T49.1 Antipruritics
0.514 0.486 0.000
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified
0.514 0.486 0.000
T47.1 Other antacids and anti-gastric-secretion drugs
0.510 0.489 0.000
C44.9 Malignant neoplasm of skin, unspecified
0.000 0.499 0.501
T44.9 Other and unspecified drugs primarily affecting the nervous system
0.493 0.507 0.000
T50.8 Diagnostic agents
0.489 0.511 0.000
T45.5 Anticoagulants
0.444 0.556 0.000
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified
0.408 0.592 0.000
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics
0.362 0.638 0.000
C44.4 Skin of scalp and neck
0.000 0.662 0.338
T39.4 Antirheumatics, not elsewhere classified
0.259 0.741 0.000
T39.2 Pyrazolone derivatives
0.259 0.741 0.000
T39.8 Other nonopioid analgesics and antipyretics, not elsewhere classified
0.258 0.742 0.000
T39.1 4-Aminophenol derivatives
0.237 0.763 0.000
T39.9 Nonopioid analgesic, antipyretic and antirheumatic, unspecified
0.233 0.767 0.000
T39.3 Other nonsteroidal anti-inflammatory drugs [NSAID]
0.216 0.784 0.000
C34.1 Upper lobe, bronchus or lung
0.000 0.794 0.206
C34 Malignant neoplasm of bronchus and lung
0.000 0.794 0.206
C32 Malignant neoplasm of larynx
0.000 0.801 0.199
C34.3 Lower lobe, bronchus or lung
0.000 0.803 0.197
C30-C39 Malignant neoplasms of respiratory and intrathoracic organs
0.000 0.803 0.197
C32.0 Glottis
0.000 0.809 0.191
C43-C44 Melanoma and other malignant neoplasms of skin
0.000 0.813 0.187
C32.9 Larynx, unspecified
0.000 0.820 0.180
C32.1 Supraglottis
0.000 0.826 0.174
C34.9 Bronchus or lung, unspecified
0.000 0.833 0.167
C37 Malignant neoplasm of thymus
0.000 0.841 0.159
T39.0 Salicylates
0.155 0.845 0.000
C34.2 Middle lobe, bronchus or lung
0.000 0.848 0.152
C30 Malignant neoplasm of nasal cavity and middle ear
0.000 0.854 0.146
C32.8 Overlapping lesion of larynx
0.000 0.857 0.143
C32.3 Laryngeal cartilage
0.000 0.857 0.143
C32.2 Subglottis
0.000 0.857 0.143
C39 Malignant neoplasm of other and ill-defined sites in the respiratory system and intrathoracic organs
0.000 0.859 0.141
C31 Malignant neoplasm of accessory sinuses
0.000 0.861 0.139
C34.8 Overlapping lesion of bronchus and lung
0.000 0.866 0.134
C33 Malignant neoplasm of trachea
0.000 0.868 0.132
C38 Malignant neoplasm of heart, mediastinum and pleura
0.000 0.880 0.120
C30.0 Nasal cavity
0.000 0.890 0.110
C30.1 Middle ear
0.000 0.895 0.105
C39.9 Ill-defined sites within the respiratory system
0.000 0.898 0.101
C39.8 Overlapping lesion of respiratory and intrathoracic organs
0.000 0.898 0.101
C39.0 Upper respiratory tract, part unspecified
0.000 0.898 0.101
C34.0 Main bronchus
0.000 0.900 0.100
C31.9 Accessory sinus, unspecified
0.000 0.900 0.100
C31.8 Overlapping lesion of accessory sinuses
0.000 0.900 0.100
C31.3 Sphenoidal sinus
0.000 0.900 0.100
C31.2 Frontal sinus
0.000 0.900 0.100
C31.1 Ethmoidal sinus
0.000 0.900 0.100
C31.0 Maxillary sinus
0.000 0.902 0.097
C38.8 Overlapping lesion of heart, mediastinum and pleura
0.000 0.914 0.086
C38.2 Posterior mediastinum
0.000 0.914 0.086
C38.1 Anterior mediastinum
0.000 0.914 0.086
C38.0 Heart
0.000 0.914 0.086
C38.3 Mediastinum, part unspecified
0.000 0.918 0.082
C38.4 Pleura
0.000 0.929 0.070
C43 Malignant melanoma of skin
0.000 0.930 0.070
C43.5 Malignant melanoma of trunk
0.000 0.933 0.067
C43.3 Malignant melanoma of other and unspecified parts of face
0.000 0.949 0.051
C43.8 Overlapping malignant melanoma of skin
0.000 0.950 0.050
C43.0 Malignant melanoma of lip
0.000 0.950 0.050
C43.9 Malignant melanoma of skin, unspecified
0.000 0.950 0.050
C43.1 Malignant melanoma of eyelid, including canthus
0.000 0.951 0.049
C43.2 Malignant melanoma of ear and external auricular canal
0.000 0.953 0.047
C44.1 Skin of eyelid, including canthus
0.000 0.962 0.038
K43.0 Ventral hernia with obstruction, without gangrene
0.037 0.963 0.000
C43.6 Malignant melanoma of upper limb, including shoulder
0.000 0.974 0.026
Z85.8 Personal history of malignant neoplasms of other organs and systems
0.000 0.978 0.022
C43.4 Malignant melanoma of scalp and neck
0.001 0.979 0.020
M19.99 Arthrosis, unspecified (Site unspecified)
0.014 0.986 0.000
C43.7 Malignant melanoma of lower limb, including hip
0.000 0.988 0.012
S02.60 Fracture of mandible (closed)
0.000 0.989 0.011
G51.0 Bell's palsy
0.011 0.989 0.000
F23.9 Acute and transient psychotic disorder, unspecified
0.010 0.990 0.000
M48.09 Spinal stenosis (Site unspecified)
0.010 0.990 0.000
M47.96 Spondylosis, unspecified (Lumbar region)
0.009 0.991 0.000
L92.9 Granulomatous disorder of skin and subcutaneous tissue, unspecified
0.000 0.991 0.009
F23 Acute and transient psychotic disorders
0.009 0.991 0.000
K43 Ventral hernia
0.008 0.992 0.000
M25.56 Pain in joint (Lower leg)
0.008 0.992 0.000
F20-F29 Schizophrenia, schizotypal and delusional disorders
0.008 0.992 0.000
F20 Schizophrenia
0.008 0.992 0.000
F20.0 Paranoid schizophrenia
0.007 0.993 0.000
C09.9 Tonsil, unspecified
0.000 0.993 0.007
F29 Unspecified nonorganic psychosis
0.007 0.993 0.000
G51 Facial nerve disorders
0.007 0.993 0.000
F23.0 Acute polymorphic psychotic disorder without symptoms of schizophrenia
0.006 0.993 0.000
G51.3 Clonic hemifacial spasm
0.007 0.993 0.000
F23.8 Other acute and transient psychotic disorders
0.006 0.993 0.000
F23.3 Other acute predominantly delusional psychotic disorders
0.006 0.993 0.000
F23.2 Acute schizophrenia-like psychotic disorder
0.006 0.993 0.000
F23.1 Acute polymorphic psychotic disorder with symptoms of schizophrenia
0.006 0.993 0.000
K43.1 Ventral hernia with gangrene
0.006 0.993 0.000
F20.9 Schizophrenia, unspecified
0.006 0.994 0.000
K43.7 Other and unspecified ventral hernia with gangrene
0.006 0.994 0.000
K43.6 Other and unspecified ventral hernia with obstruction, without gangrene
0.006 0.994 0.000
K43.5 Parastomal hernia without obstruction or gangrene
0.006 0.994 0.000
K43.4 Parastomal hernia with gangrene
0.006 0.994 0.000
K43.3 Parastomal hernia with obstruction, without gangrene
0.006 0.994 0.000
K43.2 Incisional hernia without obstruction or gangrene
0.006 0.994 0.000
S02.6 Fracture of mandible
0.001 0.994 0.005
F22 Persistent delusional disorders
0.006 0.994 0.000
M05.90 Seropositive rheumatoid arthritis, unspecified (Multiple sites)
0.000 0.994 0.006
F25 Schizoaffective disorders
0.006 0.994 0.000
F28 Other nonorganic psychotic disorders
0.006 0.994 0.000
F24 Induced delusional disorder
0.006 0.994 0.000
F21 Schizotypal disorder
0.006 0.994 0.000
F20.8 Other schizophrenia
0.006 0.994 0.000
F20.6 Simple schizophrenia
0.006 0.994 0.000
F20.4 Postschizophrenic depression
0.006 0.994 0.000
F20.3 Undifferentiated schizophrenia
0.006 0.994 0.000
F20.2 Catatonic schizophrenia
0.006 0.994 0.000
F20.1 Hebephrenic schizophrenia
0.006 0.994 0.000
F25.1 Schizoaffective disorder, depressive type
0.006 0.994 0.000
F20.5 Residual schizophrenia
0.005 0.994 0.000
G51.4 Facial myokymia
0.005 0.995 0.000
G51.2 Melkersson's syndrome
0.005 0.995 0.000
G51.1 Geniculate ganglionitis
0.005 0.995 0.000
C09 Malignant neoplasm of tonsil
0.000 0.995 0.005
F22.0 Delusional disorder
0.005 0.995 0.000
K72.9 Hepatic failure, unspecified
0.000 0.995 0.005
R06.4 Hyperventilation
0.005 0.995 0.000
S02.61 Fracture of mandible (open)
0.001 0.995 0.004
K80.0 Calculus of gallbladder with acute cholecystitis
0.005 0.995 0.000
F22.8 Other persistent delusional disorders
0.004 0.995 0.000
F25.2 Schizoaffective disorder, mixed type
0.004 0.995 0.000
F22.9 Persistent delusional disorder, unspecified
0.004 0.995 0.000
I78.1 Naevus, nonneoplastic
0.000 0.995 0.005
M05.9 Seropositive rheumatoid arthritis, unspecified
0.000 0.995 0.005
L92 Granulomatous disorders of skin and subcutaneous tissue
0.000 0.995 0.005
F25.8 Other schizoaffective disorders
0.004 0.996 0.000
D22.6 Melanocytic naevi of upper limb, including shoulder
0.000 0.996 0.004
K76.7 Hepatorenal syndrome
0.000 0.996 0.004
L92.3 Foreign body granuloma of skin and subcutaneous tissue
0.000 0.996 0.004
M05.97 Seropositive rheumatoid arthritis, unspecified (Ankle and foot)
0.000 0.996 0.004
S02.10 Fracture of base of skull (closed)
0.004 0.996 0.000
Z85.6 Personal history of leukaemia
0.004 0.996 0.000
G51.8 Other disorders of facial nerve
0.004 0.996 0.000
G51.9 Disorder of facial nerve, unspecified
0.004 0.996 0.000
G58 Other mononeuropathies
0.004 0.996 0.000
F25.0 Schizoaffective disorder, manic type
0.004 0.996 0.000
G58.9 Mononeuropathy, unspecified
0.004 0.996 0.000
M05.99 Seropositive rheumatoid arthritis, unspecified (Site unspecified)
0.000 0.996 0.004
C09.8 Overlapping lesion of tonsil
0.000 0.996 0.004
C09.1 Tonsillar pillar (anterior) (posterior)
0.000 0.996 0.004
C09.0 Tonsillar fossa
0.000 0.996 0.004
Y84.2 Radiological procedure and radiotherapy
0.000 0.996 0.004
M05.96 Seropositive rheumatoid arthritis, unspecified (Lower leg)
0.000 0.996 0.004
X62.9 Unspecified place
0.004 0.996 0.000
S02.1 Fracture of base of skull
0.004 0.996 0.000
L92.8 Other granulomatous disorders of skin and subcutaneous tissue
0.000 0.996 0.004
G58.0 Intercostal neuropathy
0.003 0.996 0.000
M05.98 Seropositive rheumatoid arthritis, unspecified (Other)
0.000 0.996 0.003
M05.93 Seropositive rheumatoid arthritis, unspecified (Forearm)
0.000 0.996 0.003
M05.92 Seropositive rheumatoid arthritis, unspecified (Upper arm)
0.000 0.996 0.003
M05.91 Seropositive rheumatoid arthritis, unspecified (Shoulder region)
0.000 0.996 0.003
L92.2 Granuloma faciale [eosinophilic granuloma of skin]
0.000 0.996 0.003
L92.1 Necrobiosis lipoidica, not elsewhere classified
0.000 0.996 0.003
C00-C14 Malignant neoplasms of lip, oral cavity and pharynx
0.000 0.996 0.004
C10.9 Oropharynx, unspecified
0.000 0.996 0.003
G58.8 Other specified mononeuropathies
0.003 0.997 0.000
G58.7 Mononeuritis multiplex
0.003 0.997 0.000
R60.9 Oedema, unspecified
0.000 0.997 0.003
C10 Malignant neoplasm of oropharynx
0.000 0.997 0.003
M25.53 Pain in joint (Forearm)
0.003 0.997 0.000
C01 Malignant neoplasm of base of tongue
0.000 0.997 0.003
S62.20 Fracture of first metacarpal bone (closed)
0.000 0.997 0.003
C14 Malignant neoplasm of other and ill-defined sites in the lip, oral cavity and pharynx
0.000 0.997 0.003
C14.0 Pharynx, unspecified
0.000 0.997 0.003
M05.94 Seropositive rheumatoid arthritis, unspecified (Hand)
0.000 0.997 0.003
C77.0 Lymph nodes of head, face and neck
0.000 0.997 0.003
G50.1 Atypical facial pain
0.003 0.997 0.000
S01.5 Open wound of lip and oral cavity
0.003 0.997 0.000
S02.11 Fracture of base of skull (open)
0.003 0.997 0.000
B34.9 Viral infection, unspecified
0.003 0.997 0.000
K72 Hepatic failure, not elsewhere classified
0.000 0.997 0.003
S02.20 Fracture of nasal bones (closed)
0.003 0.997 0.000
O69.2 Labour and delivery complicated by other cord entanglement
0.000 0.997 0.003
K72.0 Acute and subacute hepatic failure
0.000 0.997 0.003
M06.90 Rheumatoid arthritis, unspecified (Multiple sites)
0.000 0.997 0.003
M05.95 Seropositive rheumatoid arthritis, unspecified (Pelvic region and thigh)
0.000 0.997 0.003
G50-G59 Nerve, nerve root and plexus disorders
0.003 0.997 0.000
G93.9 Disorder of brain, unspecified
0.000 0.997 0.003
G50 Disorders of trigeminal nerve
0.003 0.997 0.000
C12 Malignant neoplasm of pyriform sinus
0.000 0.997 0.003
S02.2 Fracture of nasal bones
0.003 0.997 0.000
S02.80 Fractures of other skull and facial bones (closed)
0.003 0.997 0.000
S02 Fracture of skull and facial bones
0.003 0.997 0.000
O64.0 Obstructed labour due to incomplete rotation of foetal head
0.003 0.997 0.000
C13 Malignant neoplasm of hypopharynx
0.000 0.997 0.003
S02.8 Fractures of other skull and facial bones
0.003 0.997 0.000
D12.7 Rectosigmoid junction
0.000 0.997 0.003
F25.9 Schizoaffective disorder, unspecified
0.002 0.997 0.000
O03.4 Incomplete, without complication
0.003 0.997 0.000
E04.2 Non-toxic multinodular goitre
0.000 0.997 0.003
G54.8 Other nerve root and plexus disorders
0.003 0.997 0.000
M06.40 Inflammatory polyarthropathy (Multiple sites)
0.000 0.997 0.003
G54 Nerve root and plexus disorders
0.003 0.997 0.000
O69 Labour and delivery complicated by umbilical cord complications
0.000 0.997 0.003
C10.8 Overlapping lesion of oropharynx
0.000 0.997 0.003
C10.4 Branchial cleft
0.000 0.997 0.003
C10.3 Posterior wall of oropharynx
0.000 0.997 0.003
C10.2 Lateral wall of oropharynx
0.000 0.997 0.003
C10.1 Anterior surface of epiglottis
0.000 0.997 0.003
C10.0 Vallecula
0.000 0.997 0.003
G50.9 Disorder of trigeminal nerve, unspecified
0.003 0.997 0.000
K72.1 Chronic hepatic failure
0.000 0.997 0.003
O69.1 Labour and delivery complicated by cord around neck, with compression
0.000 0.997 0.003
C03 Malignant neoplasm of gum
0.000 0.997 0.003
C14.8 Overlapping lesion of lip, oral cavity and pharynx
0.000 0.997 0.003
C14.2 Waldeyer's ring
0.000 0.997 0.003
O23.4 Unspecified infection of urinary tract in pregnancy
0.000 0.997 0.003
C06 Malignant neoplasm of other and unspecified parts of mouth
0.000 0.997 0.003
H01.0 Blepharitis
0.000 0.997 0.003
S02.3 Fracture of orbital floor
0.003 0.997 0.000
C11 Malignant neoplasm of nasopharynx
0.000 0.997 0.003
C00 Malignant neoplasm of lip
0.000 0.997 0.002
M06.91 Rheumatoid arthritis, unspecified (Shoulder region)
0.000 0.997 0.003
C79.0 Secondary malignant neoplasm of kidney and renal pelvis
0.000 0.997 0.003
L92.0 Granuloma annulare
0.000 0.997 0.002
M06.93 Rheumatoid arthritis, unspecified (Forearm)
0.000 0.997 0.003
G54.6 Phantom limb syndrome with pain
0.003 0.997 0.000
M06.9 Rheumatoid arthritis, unspecified
0.000 0.997 0.003
B95.8 Unspecified staphylococcus as the cause of diseases classified to other chapters
0.000 0.997 0.003
B35.3 Tinea pedis
0.003 0.997 0.000
C04 Malignant neoplasm of floor of mouth
0.000 0.997 0.002
S02.0 Fracture of vault of skull
0.002 0.997 0.000
S62.40 Multiple fractures of metacarpal bones (closed)
0.000 0.997 0.003
I74.5 Embolism and thrombosis of iliac artery
0.000 0.997 0.003
G52 Disorders of other cranial nerves
0.002 0.997 0.000
C13.9 Hypopharynx, unspecified
0.000 0.997 0.002
I74.3 Embolism and thrombosis of arteries of the lower extremities
0.000 0.997 0.003
O69.9 Labour and delivery complicated by cord complication, unspecified
0.000 0.997 0.002
O69.0 Labour and delivery complicated by prolapse of cord
0.000 0.997 0.002
M06.92 Rheumatoid arthritis, unspecified (Upper arm)
0.000 0.997 0.002
F32.0 Mild depressive episode
0.002 0.997 0.000
S02.4 Fracture of malar and maxillary bones
0.002 0.997 0.000
M06.94 Rheumatoid arthritis, unspecified (Hand)
0.000 0.998 0.002
S02.30 Fracture of orbital floor (closed)
0.002 0.998 0.000
O69.8 Labour and delivery complicated by other cord complications
0.000 0.998 0.002
B35.1 Tinea unguium
0.002 0.998 0.000
R27.8 Other and unspecified lack of coordination
0.000 0.998 0.002
C05 Malignant neoplasm of palate
0.000 0.998 0.002
N81.9 Female genital prolapse, unspecified
0.000 0.998 0.002
C08 Malignant neoplasm of other and unspecified major salivary glands
0.000 0.998 0.002
M06.97 Rheumatoid arthritis, unspecified (Ankle and foot)
0.000 0.998 0.002
S02.21 Fracture of nasal bones (open)
0.002 0.998 0.000
C13.8 Overlapping lesion of hypopharynx
0.000 0.998 0.002
C13.2 Posterior wall of hypopharynx
0.000 0.998 0.002
C13.1 Aryepiglottic fold, hypopharyngeal aspect
0.000 0.998 0.002
G50.8 Other disorders of trigeminal nerve
0.002 0.998 0.000
J38.3 Other diseases of vocal cords
0.000 0.998 0.002
C13.0 Postcricoid region
0.000 0.998 0.002
G54.2 Cervical root disorders, not elsewhere classified
0.002 0.998 0.000
S02.81 Fractures of other skull and facial bones (open)
0.002 0.998 0.000
Z22.3 Carrier of other specified bacterial diseases
0.000 0.998 0.002
G52.1 Disorders of glossopharyngeal nerve
0.002 0.998 0.000
S62.50 Fracture of thumb (closed)
0.002 0.998 0.000
B34.4 Papovirus infection, unspecified
0.002 0.998 0.000
I05.9 Mitral valve disease, unspecified
0.002 0.998 0.000
G54.4 Lumbosacral root disorders, not elsewhere classified
0.002 0.998 0.000
Chapter II Neoplasms
0.000 0.998 0.002
G54.7 Phantom limb syndrome without pain
0.002 0.998 0.000
G54.5 Neuralgic amyotrophy
0.002 0.998 0.000
G54.3 Thoracic root disorders, not elsewhere classified
0.002 0.998 0.000
M06.4 Inflammatory polyarthropathy
0.000 0.998 0.002
O69.5 Labour and delivery complicated by vascular lesion of cord
0.000 0.998 0.002
O69.4 Labour and delivery complicated by vasa praevia
0.000 0.998 0.002
O69.3 Labour and delivery complicated by short cord
0.000 0.998 0.002
S72.10 Pertrochanteric fracture (closed)
0.002 0.998 0.000
C06.2 Retromolar area
0.000 0.998 0.002
I78 Diseases of capillaries
0.000 0.998 0.002
S02.00 Fracture of vault of skull (closed)
0.002 0.998 0.000
C00.9 Lip, unspecified
0.000 0.998 0.002
C03.9 Gum, unspecified
0.000 0.998 0.002
C03.0 Upper gum
0.000 0.998 0.002
C77.9 Lymph node, unspecified
0.000 0.998 0.002
G54.1 Lumbosacral plexus disorders
0.002 0.998 0.000
C07 Malignant neoplasm of parotid gland
0.000 0.998 0.002
G53 Cranial nerve disorders in diseases classified elsewhere
0.002 0.998 0.000
C06.9 Mouth, unspecified
0.000 0.998 0.002
E73.9 Lactose intolerance, unspecified
0.002 0.998 0.000
C06.8 Overlapping lesion of other and unspecified parts of mouth
0.000 0.998 0.002
C06.1 Vestibule of mouth
0.000 0.998 0.002
R40.0 Somnolence
0.000 0.998 0.002
S02.31 Fracture of orbital floor (open)
0.002 0.998 0.000
C00.8 Overlapping lesion of lip
0.000 0.998 0.002
C00.6 Commissure of lip
0.000 0.998 0.002
C00.5 Lip, unspecified, inner aspect
0.000 0.998 0.002
C00.4 Lower lip, inner aspect
0.000 0.998 0.002
C00.3 Upper lip, inner aspect
0.000 0.998 0.002
C00.2 External lip, unspecified
0.000 0.998 0.002
C00.0 External upper lip
0.000 0.998 0.002
C11.8 Overlapping lesion of nasopharynx
0.000 0.998 0.002
C11.3 Anterior wall of nasopharynx
0.000 0.998 0.002
C11.2 Lateral wall of nasopharynx
0.000 0.998 0.002
C11.1 Posterior wall of nasopharynx
0.000 0.998 0.002
C11.0 Superior wall of nasopharynx
0.000 0.998 0.002
I74.2 Embolism and thrombosis of arteries of the upper extremities
0.000 0.998 0.002
M47.9 Spondylosis, unspecified
0.002 0.998 0.000
B34 Viral infection of unspecified site
0.002 0.998 0.000
G59 Mononeuropathy in diseases classified elsewhere
0.002 0.998 0.000
E24.9 Cushing's syndrome, unspecified
0.000 0.998 0.002
S02.7 Multiple fractures involving skull and facial bones
0.002 0.998 0.000
C03.1 Lower gum
0.000 0.998 0.002
C04.8 Overlapping lesion of floor of mouth
0.000 0.998 0.002
C04.1 Lateral floor of mouth
0.000 0.998 0.002
C05.0 Hard palate
0.000 0.998 0.002
I78.0 Hereditary haemorrhagic telangiectasia
0.000 0.998 0.002
S02.40 Fracture of malar and maxillary bones (closed)
0.002 0.998 0.000
C04.9 Floor of mouth, unspecified
0.000 0.998 0.002
G54.0 Brachial plexus disorders
0.002 0.998 0.000
S02.01 Fracture of vault of skull (open)
0.002 0.998 0.000
S02.41 Fracture of malar and maxillary bones (open)
0.002 0.998 0.000
D03.3 Melanoma in situ of other and unspecified parts of face
0.002 0.998 0.000
G52.7 Disorders of multiple cranial nerves
0.002 0.998 0.000
G52.2 Disorders of vagus nerve
0.002 0.998 0.000
G52.0 Disorders of olfactory nerve
0.002 0.998 0.000
M05 Seropositive rheumatoid arthritis
0.000 0.998 0.002
M47.98 Spondylosis, unspecified (Sacral and sacrococcygeal region)
0.002 0.998 0.000
G52.8 Disorders of other specified cranial nerves
0.002 0.998 0.000
S02.9 Fracture of skull and facial bones, part unspecified
0.002 0.998 0.000
C05.8 Overlapping lesion of palate
0.000 0.998 0.002
C05.2 Uvula
0.000 0.998 0.002
L72.9 Follicular cyst of skin and subcutaneous tissue, unspecified
0.000 0.998 0.002
C08.8 Overlapping lesion of major salivary glands
0.000 0.998 0.002
C08.1 Sublingual gland
0.000 0.998 0.002
W44.0 Home
0.000 0.998 0.002
B35 Dermatophytosis
0.002 0.998 0.000
I74 Arterial embolism and thrombosis
0.000 0.998 0.002
C11.9 Nasopharynx, unspecified
0.000 0.998 0.002
G52.9 Cranial nerve disorder, unspecified
0.002 0.998 0.000
H90.1 Conductive hearing loss, unilateral with unrestricted hearing on the contralateral side
0.000 0.998 0.002
M47.97 Spondylosis, unspecified (Lumbosacral region)
0.002 0.998 0.000
C77 Secondary and unspecified malignant neoplasm of lymph nodes
0.000 0.998 0.002
C06.0 Cheek mucosa
0.000 0.998 0.002
G52.3 Disorders of hypoglossal nerve
0.002 0.998 0.000
G93.1 Anoxic brain damage, not elsewhere classified
0.000 0.998 0.002
C00.1 External lower lip
0.000 0.998 0.002
M25.54 Pain in joint (Hand)
0.002 0.998 0.000
M25.5 Pain in joint
0.002 0.998 0.000
O23.9 Other and unspecified genito-urinary tract infection in pregnancy
0.000 0.998 0.002
Z43.1 Attention to gastrostomy
0.000 0.998 0.002
M06.49 Inflammatory polyarthropathy (Site unspecified)
0.000 0.998 0.002
M06.48 Inflammatory polyarthropathy (Other)
0.000 0.998 0.002
M06.47 Inflammatory polyarthropathy (Ankle and foot)
0.000 0.998 0.002
M06.46 Inflammatory polyarthropathy (Lower leg)
0.000 0.998 0.002
M06.45 Inflammatory polyarthropathy (Pelvic region and thigh)
0.000 0.998 0.002
M06.44 Inflammatory polyarthropathy (Hand)
0.000 0.998 0.002
M06.43 Inflammatory polyarthropathy (Forearm)
0.000 0.998 0.002
M06.42 Inflammatory polyarthropathy (Upper arm)
0.000 0.998 0.002
M06.41 Inflammatory polyarthropathy (Shoulder region)
0.000 0.998 0.002
M06.98 Rheumatoid arthritis, unspecified (Other)
0.000 0.998 0.002
K35.8 Acute appendicitis, other and unspecified
0.000 0.998 0.002

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

 

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

This website was created, designed, and edited by ORCID iD iconPatrick K. Albers

The contents of TreeWAS.org are available under the Creative Commons Attribution 4.0 International License (CC BY 4.0) with attribution (citation) required.

TreeWAS Database © 2019 - 2024 About Frequently Asked Questions Citation Contact Terms & Conditions This website does not use cookies to collect any personal information about you.